Karyopharm Therapeutics Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
Karyopharm Therapeutics Inc. (KPTI) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $96.62 million as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-03-15
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $96.62M.
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $81.28M.
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $103.50M.
- 2017-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $75.99M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2017-12-31 | $96.62M 10-K · filed 2018-03-15 |
| 2017-09-30 | $81.28M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $103.50M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $75.99M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $95.95M 10-K · filed 2018-03-15 |
| 2016-09-30 | $70.52M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $25.41M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $26.46M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $117.85M 10-K · filed 2017-03-16 |
| 2015-09-30 | $78.78M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $116.24M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $91.98M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $12.63M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |